IFNG and neoplasm: This approach has been demonstrated to enhance CD107a expression (a marker of degranulation), as well as secretion of effector molecules, such as IFN-γ and granzyme B, by both CAR T-cells and endogenous tumor-specific T-cells, suggesting a broader restoration of anti-tumor immunity (98–100).